Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HKSE:01501'
s EV-to-FCF Range Over the Past 10 Years
Min: -546.51 Med: -33.54 Max: 207.14
Current: 27.99
During the past 10 years, the highest EV-to-FCF of Shanghai INT Medical Instruments Co was 207.14. The lowest was -546.51. And the median was -33.54.
HKSE:01501's EV-to-FCF is ranked worse than 57.14% of 406
companies
in the Medical Devices & Instruments industry
Industry Median: 24.66
vs HKSE:01501: 27.99
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shanghai INT Medical Instruments Co (HKSE:01501) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shanghai INT Medical Instruments Co's PE Ratio (TTM) for today is calculated as:
Shanghai INT Medical Instruments Co's share price for today is HK$33.40.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shanghai INT Medical Instruments Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$1.385.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Shanghai INT Medical Instruments Co EV-to-FCF Related Terms
Shanghai INT Medical Instruments Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai INT Medical Instruments Co EV-to-FCF Chart
HKSE:01501 vs ISRG, BDX, MDLN: EV-to-FCF Comparison
For the Medical Instruments & Supplies subindustry, Shanghai INT Medical Instruments Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai INT Medical Instruments Co EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shanghai INT Medical Instruments Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Shanghai INT Medical Instruments Co's EV-to-FCF falls into.
Shanghai INT Medical Instruments Co's current Enterprise Value is HK$7,197 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shanghai INT Medical Instruments Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$257 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai INT Medical Instruments Co (HKSE:01501) has a EV-to-FCF of 27.99 as of Aug. 16, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shanghai INT Medical Instruments Co and its competitors. According to the industry distribution chart, Shanghai INT Medical Instruments Co ranks #232 out of 406 companies in the Medical Devices & Instruments industry, placing it in the top 57.1%.
Is Shanghai INT Medical Instruments Co's EV-to-FCF too high?
Shanghai INT Medical Instruments Co's current EV-to-FCF is 27.99. The Medical Devices & Instruments industry median EV-to-FCF is 24.66. Shanghai INT Medical Instruments Co's value of 27.99 is 13.5% above this industry median. Based on the distribution chart, Shanghai INT Medical Instruments Co ranks #232 out of 406 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Shanghai INT Medical Instruments Co has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai INT Medical Instruments Co's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shanghai INT Medical Instruments Co ranks #232 out of 406 companies for EV-to-FCF. This places Shanghai INT Medical Instruments Co in the lower half of its industry. The industry median EV-to-FCF is 24.66. Shanghai INT Medical Instruments Co's value of 27.99 is 13.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 24.66, based on 406 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai INT Medical Instruments Co's current EV-to-FCF of 27.99 is 13.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shanghai INT Medical Instruments Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 24.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai INT Medical Instruments Co's current EV-to-FCF is 27.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai INT Medical Instruments Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai INT Medical Instruments Co (HKSE:01501) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$40.20, compared to a current price of HK$33.40 — trading 16.9% below its estimated fair value. The current EV-to-FCF is 27.99 and 13.5% above the Medical Devices & Instruments industry median of 24.66. Shanghai INT Medical Instruments Co's overall GF Score™ is 94/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Shanghai INT Medical Instruments Co (HKSE:01501), the current EV-to-FCF is 27.99 as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai INT Medical Instruments Co (HKSE:01501) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai INT Medical Instruments Co stock appears to be undervalued.
The current stock price of HK$33.40 is trading 16.9% below its estimated GF Value™ of HK$40.20.
GuruFocus considers Shanghai INT Medical Instruments Co to be Modestly Undervalued.
Key valuation signals for HKSE:01501:
EV-to-FCF: 27.99
GF Value™: HK$40.20 vs. price of HK$33.40 (16.9% below fair value)
Industry Position: 13.5% above the Medical Devices & Instruments median (#232 of 406)
No single metric tells the full story. See the HKSE:01501 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai INT Medical Instruments Co Ltd engages in the design and development of medical devices used in fields including peripheral intervention, neurological intervention, cardiovascular intervention, or implantation, and the design and development of equipment and moulds used for the production of medical devices. The company operates in the Chinese Mainland, Europe, the United States, and Other countries and regions. The majority of the revenue comes from the Chinese Mainland.
94GF Score
Get the complete analysis for HKSE:01501
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01501 has been successfully added to your 
